Spinosad structure
|
Common Name | Spinosad | ||
|---|---|---|---|---|
| CAS Number | 168316-95-8 | Molecular Weight | 734.014 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 776.3±60.0 °C at 760 mmHg | |
| Molecular Formula | C42H71NO9 | Melting Point | 84ºC to 99.5ºC | |
| MSDS | USA | Flash Point | 423.3±32.9 °C | |
| Symbol |
GHS09 |
Signal Word | Warning | |
Use of SpinosadSpinosad, a mixture of spinosyns A and D known as fermentation products of a soil actinomycete (Saccharopolyspora spinosa), is a biological neurotoxic insecticide with a broader action spectrum. Spinosad targets the nicotinic acetylcholine receptor (nAChRs) of the insect nervous system. Spinosad has an excellent environmental and mammalian toxicological profile. Larvicidal activity[1][2][3]. |
| Name | spinosad |
|---|---|
| Synonym | More Synonyms |
| Description | Spinosad, a mixture of spinosyns A and D known as fermentation products of a soil actinomycete (Saccharopolyspora spinosa), is a biological neurotoxic insecticide with a broader action spectrum. Spinosad targets the nicotinic acetylcholine receptor (nAChRs) of the insect nervous system. Spinosad has an excellent environmental and mammalian toxicological profile. Larvicidal activity[1][2][3]. |
|---|---|
| Related Catalog | |
| In Vitro | Spinosad acts as an allosteric agonist of acetylcholine (Ach) by binding to nicotinicacetylcholine receptors (nAChRs), prototypicalunits that function as neurotransmitter ligand-gated ion channels[4]. |
| In Vivo | Spinosad is a natural mixture of the pediculicidal tetracyclic macrolides spinosyn A and spinosyn D. Spinosad 0.9% mainly interferes with nicotinic acetylcholine receptors in insects, thereby producing neuronal excitation that results in paralysis of lice from neuromuscular fatigue after extended periods of hyperexcitation. Spinosad 0.9% kills both permethrin-susceptible and permethrin-resistant populations of lice. It is also ovicidal, killing both eggs (nits) and lice[5]. Spinosad causes in vivo oxidative effects in the brain of Oreochromis niloticus. Spinosad causes elevations in the contents of tGSH, GSH, GSSG, Hsp70, and reductions in the ratio of GSH/GSSG and GPx activity and an induction in the GR (glutathione reducta) activity. Spinosad has oxidative effects in the brain tissue by altering the parameters in GSH-related antioxidant system and Hsp70[6]. |
| References |
[4]. McCormack PL. Spinosad: in pediculosis capitis. Am J Clin Dermatol. 2011;12(5):349-353. |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 776.3±60.0 °C at 760 mmHg |
| Melting Point | 84ºC to 99.5ºC |
| Molecular Formula | C42H71NO9 |
| Molecular Weight | 734.014 |
| Flash Point | 423.3±32.9 °C |
| Exact Mass | 733.512878 |
| PSA | 101.99000 |
| LogP | 4.86 |
| Vapour Pressure | 0.0±2.7 mmHg at 25°C |
| Index of Refraction | 1.527 |
| Storage condition | 0-6°C |
| 13-{[5-(Dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl]oxy}-9-ethyl-14-methyl-2-[(2,3,4-trimethoxy-5-methylcyclohexyl)oxy]octadecahydro-1H-as-indaceno[3,2-d]oxacyclododecine-7,15-dione |
| 1H-as-Indaceno[3,2-d]oxacyclododecin-7,15-dione, 13-[[5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl]oxy]-9-ethyloctadecahydro-14-methyl-2-[(2,3,4-trimethoxy-5-methylcyclohexyl)oxy]- |
| Spinosyn A |